TIL FY 2023 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$159M

Net Income

-$156M

EPS (Diluted)

$-24.00

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$103M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$326M

Total Liabilities

$100M

Stockholders' Equity

$226M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$6M	+100.0%
Operating Income	-$159M	-$206M	+22.8%
Net Income	-$156M	-$223M	+30.1%